Pot Stock Alert: This Company Just Spiked 146%

Hexo Corp (TSX:HEXO)(NYSE:HEXO) is one of the hottest pot stocks on the market. In recent weeks, shares have more than doubled in value.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Pot stocks have been a roller coaster ride this year. At the start of 2020, cannabis companies were hit hard by the coronavirus correction. These pressures came after the terrible marijuana bear market of 2019, which saw industry valuations cut in half.

Recent weeks, however, have brought much-needed relief. Indeed, some companies are seeing their share prices soar.

One of the leaders has been Hexo Corp (TSX:HEXO)(NYSE:HEXO). Since hitting an all-time low on March 18, shares have surged more than 140%! But here’s the thing: this stock is just getting started.

The cannabis market is booming

Last week we got some exciting news: Canadian medical cannabis oil exports spiked by 500% in 2019. Health Canada reported that cannabis oil was exported to at 17 countries for medical and scientific purposes last year.

The total amount exported was roughly 5,372.3 liters. It’s a big reason why pot stocks have been zooming higher.

Canada is also becoming a global leader for dry flower exports. In addition to the oil exports in 2019, 3,740 kilograms of cannabis flowers were sent abroad. That’s a 180% rise year over year.

Why is this fantastic news for Canada? Well, it means Canadian marijuana producers have a front-row seat for meeting global demand, thereby increasing the potential market size by at least 1,000%.

“Anybody looking to export now is going to be looking at paths that are already open,” says Seale & Garland Consulting CEO Sarah Seale. “Canada has the opportunity of looking at the paths that aren’t open yet and making provisions to be the first one in the door in those markets as well.”

Pot stocks that capitalize on this opportunity will win.

“A lot of countries don’t have provisions in place to produce dried flower and oil products, so they’re going to look to other countries to be able to obtain those product formats,” adds CannDelta CEO Sherry Boodram.

This pot stock is ready

The name of the game right now is exports. But there’s a catch: Eventually, the export game will become commoditized. This will be especially true once foreign consumers establish ample domestic supply.

What’s the secret to success? Branding.

Coca-Cola Co and PepsiCo, Inc. are perfect examples of how branding can overcome the commodity trap. The constituent ingredients for their products are pure commodities, namely sugar and water. Yet consumers pay steep premiums for these low-value inputs.

Why? Because customers are buying the brand, not the separate ingredients.

Today, Coca-Cola and Pepsi products are exported globally, even though they are relatively easy to concoct domestically. Pot stocks that can replicate this model will win. Hexo Corp has the lead.

At the start of the cannabis boom, nearly every cannabis producer rushed to bring supply online. In contrast, Hexo decided to take a brand-first approach. It sought to seek partnerships with existing brands rather than go it alone.

This year, for example, it plans to launch its first co-branded product with Molson Coors, a brand that millions of consumers already know and love.

Just ask yourself what’s more likely to succeed: a THC beverage from an unknown startup, or a THC beverage from Molson Coors? Hexo is betting on the latter.

This year, this pot stock aims to secure additional partnerships in new categories like sleep aids, cosmetics, and edibles.

If it succeeds in creating a cannabis brand powerhouse, shares will rise significantly more than the current $500 million valuation.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »